214 related articles for article (PubMed ID: 34009525)
1. Enteropathy-Associated T cell Lymphoma.
Al Somali Z; Hamadani M; Kharfan-Dabaja M; Sureda A; El Fakih R; Aljurf M
Curr Hematol Malig Rep; 2021 Apr; 16(2):140-147. PubMed ID: 34009525
[TBL] [Abstract][Full Text] [Related]
2. How I treat enteropathy-associated T-cell lymphoma.
Di Sabatino A; Biagi F; Gobbi PG; Corazza GR
Blood; 2012 Mar; 119(11):2458-68. PubMed ID: 22271451
[TBL] [Abstract][Full Text] [Related]
3. [Acute intestinal obstruction revealing enteropathy associated t-cell lymphoma, about a case].
Garba AA; Adamou H; Magagi IA; Brah S; Habou O
Pan Afr Med J; 2016; 23():48. PubMed ID: 27217874
[TBL] [Abstract][Full Text] [Related]
4. A case of celiac disease with type I enteropathy-associated T-cell lymphoma in a Japanese male patient.
Hiraga H; Sakuraba H; Tanaka N; Watanabe R; Akemoto Y; Ota S; Kikuchi H; Sawaya M; Hiraga N; Chinda D; Hanabata N; Mikami T; Shimoyama T; Takahata T; Tanaka M; Fukuda S
Immunol Med; 2019 Sep; 42(3):142-147. PubMed ID: 31603739
[TBL] [Abstract][Full Text] [Related]
5. Patients with enteropathy-associated T-cell lymphoma in the United States from 2000 to 2018: SEER data-base analysis.
Awad AK; Awan RU; Awad AK; Nabeel A; Dar S; Abegunde AT
Cancer Treat Res Commun; 2023; 36():100745. PubMed ID: 37499419
[TBL] [Abstract][Full Text] [Related]
6. Refractory celiac disease and EATL patients show severe malnutrition and malabsorption at diagnosis.
Wierdsma NJ; Nijeboer P; de van der Schueren MA; Berkenpas M; van Bodegraven AA; Mulder CJ
Clin Nutr; 2016 Jun; 35(3):685-91. PubMed ID: 25979847
[TBL] [Abstract][Full Text] [Related]
7. Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies.
Sieniawski MK; Lennard AL
Curr Hematol Malig Rep; 2011 Dec; 6(4):231-40. PubMed ID: 21912848
[TBL] [Abstract][Full Text] [Related]
8. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.
Chan JK; Chan AC; Cheuk W; Wan SK; Lee WK; Lui YH; Chan WK
Am J Surg Pathol; 2011 Oct; 35(10):1557-69. PubMed ID: 21921780
[TBL] [Abstract][Full Text] [Related]
9. Enteropathy-associated T-cell lymphoma: improving treatment strategies.
Nijeboer P; Malamut G; Mulder CJ; Cerf-Bensussan N; Sibon D; Bouma G; Cellier C; Hermine O; Visser O
Dig Dis; 2015; 33(2):231-235. PubMed ID: 25925928
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic Findings of Enteropathy-Associated T-Cell Lymphoma Type II: A Case Series.
Hong YS; Woo YS; Park G; Lee K; Kang SH; Lee HW; Kim ER; Hong SN; Chang DK; Kim YH; Rhee PL; Kim JJ
Gut Liver; 2016 Jan; 10(1):147-51. PubMed ID: 26260757
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Enteropathy-Associated T Cell Lymphoma.
Chander U; Leeman-Neill RJ; Bhagat G
Curr Hematol Malig Rep; 2018 Aug; 13(4):308-317. PubMed ID: 29943210
[TBL] [Abstract][Full Text] [Related]
13. A case of enteropathy-associated T-cell lymphoma (type I) arising in stomach without refractory celiac disease.
Wang L; Liu Y; Lin XY; Yu JH; Miao Y; Qiu XS; Wang EH
Diagn Pathol; 2012 Dec; 7():172. PubMed ID: 23217032
[TBL] [Abstract][Full Text] [Related]
14. A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma.
de Baaij LR; Berkhof J; van de Water JM; Sieniawski MK; Radersma M; Verbeek WH; Visser OJ; Oudejans JJ; Meijer CJ; Mulder CJ; Lennard AL; Cillessen SA
Clin Cancer Res; 2015 Jul; 21(13):3013-9. PubMed ID: 25779949
[TBL] [Abstract][Full Text] [Related]
15. Multiple cerebral lesions in a patient with refractory celiac disease: A case report.
Horvath L; Oberhuber G; Chott A; Effenberger M; Tilg H; Gunsilius E; Wolf D; Iglseder S
World J Gastroenterol; 2020 Dec; 26(47):7584-7592. PubMed ID: 33384556
[TBL] [Abstract][Full Text] [Related]
16. Monitoring nonresponsive patients who have celiac disease.
Krauss N; Schuppan D
Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.
Sieniawski M; Angamuthu N; Boyd K; Chasty R; Davies J; Forsyth P; Jack F; Lyons S; Mounter P; Revell P; Proctor SJ; Lennard AL
Blood; 2010 May; 115(18):3664-70. PubMed ID: 20197551
[TBL] [Abstract][Full Text] [Related]
18. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.
Delabie J; Holte H; Vose JM; Ullrich F; Jaffe ES; Savage KJ; Connors JM; Rimsza L; Harris NL; Müller-Hermelink K; Rüdiger T; Coiffier B; Gascoyne RD; Berger F; Tobinai K; Au WY; Liang R; Montserrat E; Hochberg EP; Pileri S; Federico M; Nathwani B; Armitage JO; Weisenburger DD
Blood; 2011 Jul; 118(1):148-55. PubMed ID: 21566094
[TBL] [Abstract][Full Text] [Related]
19. Complications of coeliac disease.
Malamut G; Cellier C
Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):451-8. PubMed ID: 26060109
[TBL] [Abstract][Full Text] [Related]
20. The MYO9B gene is a strong risk factor for developing refractory celiac disease.
Wolters VM; Verbeek WH; Zhernakova A; Onland-Moret C; Schreurs MW; Monsuur AJ; Verduijn W; Wijmenga C; Mulder CJ
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1399-405, 1405.e1-2. PubMed ID: 17967566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
